David A. Gorelick, MD, PhD

Professor of Psychiatry
University of Maryland School of Medicine, Baltimore, MD

Scientific Director
Clinical Neurobehavioral Center at University of Maryland, Baltimore, MD

David A. Gorelick, MD, PhD is currently Professor of Psychiatry (part-time) at the University of Maryland School of Maryland, having retired in 2013 after 24 years at the Intramural Research Program of the National Institute on Drug Abuse (NIDA), US National Institutes of Health (NIH) in Baltimore, MD, US. Dr. Gorelick is board certified in psychiatry and addiction medicine, a distinguished life fellow of the American Psychiatric Association, and a fellow of the American Society of Addiction Medicine. He received his M.D. and Ph.D. (pharmacology) degrees from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY in 1976, and did his medical internship and psychiatric residency at the University of California, Los Angeles.

His research interests are the clinical pharmacology of substance use disorders and their biological treatment, including medication, drug-metabolizing enzymes, and transcranial magnetic stimulation (TMS). Dr. Gorelick has published more than 200 peer-reviewed scientific articles and 50 book chapters. His recent work focuses on cannabis and its therapeutic uses, cocaine, and individuals with comorbid psychiatric disorders. He has organized workshops on medical cannabis at annual meetings of the American Psychiatric Association and American Society of Addiction Medicine, presented on the topic at national and international conferences, and is editor-in-chief of the Journal of Cannabis Research.